Health TrialsbyHealthPanel

Osseodensification Versus Alveolar Ridge Splitting

ConditionsMaxillary DeficiencyHorizontal Alveolar Bone Defect
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFayoum University

About this trial

Evaluation of clinical and radiological outcomes of the alveolar ridge splitting technique versus Osseodensification burs in atrophic maxillary alveolar ridges in horizontal dimension.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • A Horizontal Ridge Augmentation in Atrophic Maxillary Ridge

    Procedure/Surgery

    Aiming to enhance bone volume (Quantity) in horizontal maxillary bone defects and density (Quality) , providing a viable solution for implant stability and long-term success.

Treatment groups

46 Participants
are divided into 2 treatment groups
Group A: Alveolar ridge split group:Active comparator 1 intervention
Group B: Implant placement in pristine bone with Osseodensification burs group:Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Gained bone width :

will be measured immediately after surgery by CBCT using the following reference points: 1. Ridge width (RW): the distance between the buccal and palatal border of the bone at the crest. 2. Buccal bone thickness (BBT): the distance from the implant surface to the outer margin of bone. All variables will be measured twice with an interval of 1 week between measurements.

Time frame
preoperative , immediate postoperative and 6 months postoperative.

Secondary outcomes

1

Bone density :

CBCT to measure difference in bone density of newly formed bone at implant-crestal margin using the gray scale.

Time frame
Immediate post operative and 6 months postoperative
2

primary stability:

we measure using insertion Smartpeg specific for the implant system and restorative platform diameter will be used for each implant and perform a resonance frequency analysis using an OsstellMentor device18 (Ostell/Integration Diagnostics,Gothenburg, Sweden) to record ISQ19 values in all implant surfaces.

Time frame
immediately and 6 months post-operative

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fayoum University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: